Many studies have been conducted to find the most accurate method for determining EGFR mutations in the cftDNA of lung cancer patients, including technologies such as ARMS [39,40], PNA-clamp [41], DHPLC [42], and NGS [29]. The gene discussed is EGFR; the disease is lung carcinoma.